JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Johnson, K. B. Articles by McJames, S. W. Search for Related Content PubMed PubMed Citation Articles by Johnson, K. B. Articles by McJames, S. W. Related Collections Cardiovascular Critical Care Pharmacology

---

ANESTHETIC PHARMACOLOGY

The Influence of Hemorrhagic Shock on Etomidate: A Pharmacokinetic and Pharmacodynamic Analysis

Department of Anesthesiology, University of Utah School of Medicine, Salt Lake City, Utah

Address correspondence and reprint requests to Ken B. Johnson, MD, Department of Anesthesiology, University of Utah School of Medicine, Salt Lake City, UT 84132. Address e-mail to kjohnson{at}anesth.med.utah.edu

We studied the influence of hemorrhagic shock on the pharmacology of etomidate in swine. Sixteen swine were randomly assigned to control and shock groups. The shock group was bled to a mean arterial blood pressure of 50 mm Hg and held there until 30 mL/kg blood was removed. Etomidate 300 µg · kg^-1 · min^-1 was infused for 10 min to both groups. Fifteen arterial samples were collected until 180 min after the infusion began to determine drug concentration. Pharmacokinetic variables for each group were estimated by using a three-compartment model. The bispectral index scale was used as a measure of drug effect. The pharmacodynamics were characterized by using a sigmoid inhibitory maximal effect model. The raw data revealed a 25% increase in the plasma etomidate concentration at the end of the 10-min infusion which resolved after termination of the infusion in the shock group. The pharmacokinetic analysis revealed subtle changes in the variable estimates between groups. The etomidate infusion produced a similar Bispectral Index Scale change in both groups. These results demonstrated that, unlike the influence of hemorrhagic shock on other sedative hypnotics and opioids, moderate hemorrhagic shock produced minimal changes in the pharmacokinetics and no change in the pharmacodynamics of etomidate.

IMPLICATIONS: Hemorrhagic shock produced minimal changes in the pharmacokinetics and no change in the pharmacodynamics of etomidate in swine. These results suggest that, unlike other sedative hypnotics and opioids, minimal adjustment in the dose of etomidate is required to achieve the same drug effect during hemorrhagic shock.

This article has been cited by other articles:

				C. Grasshoff, R. Jurd, U. Rudolph, and B. Antkowiak Modulation of Presynaptic beta3-Containing GABAA Receptors Limits the Immobilizing Actions of GABAergic Anesthetics Mol. Pharmacol., September 1, 2007; 72(3): 780 - 787. [Abstract] [Full Text] [PDF]

				T. Mitsuyo, J. F. Antognini, and E. Carstens Etomidate depresses lumbar dorsal horn neuronal responses to noxious thermal stimulation in rats. Anesth. Analg., April 1, 2006; 102(4): 1169 - 1173. [Abstract] [Full Text] [PDF]

				J Easby and C Dodds Emergency induction of anaesthesia in the prehospital setting: a review of the anaesthetic induction agents Trauma, July 1, 2004; 6(3): 217 - 224. [Abstract] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999